Article Information
History
- November 4, 2020.
Article Versions
- You are currently viewing Version 1 of this article (November 4, 2020 - 06:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- David Wyllie, Consultant Microbiologist1,+,
- Ranya Mulchandani, Field Epidemiology Training Programme (UK-FETP) Fellow1,
- Hayley E Jones, Senior Lecturer2,
- Sian Taylor-Phillips, Professor3,
- Tim Brooks, Consultant Microbiologist1,
- Andre Charlett, Head of Statistics and Modelling1,
- Anthony E Ades, Professor2,
- EDSAB-HOME investigators,
- Andrew Makin, Vice President, Medical Affairs4,
- Isabel Oliver, Director, National Infection Service1,
- Philippa Moore, Consultant Microbiologist5,
- John Boyes, Consultant Microbiologist5,
- Anil Hormis, Consultant Anaesthetist6,
- Neil Todd, Consultant Microbiologist7 and
- Ian Reckless, Consultant Physician8
- 1Public Health England
- 2University of Bristol
- 3University of Warwick
- 4Oxford Immunotec Ltd
- 5Gloucestershire Hospitals, NHS Foundation Trust, Gloucester, UK
- 6The Rotherham NHS Foundation Trust, Rotherham, UK
- 7York Teaching Hospital NHS Foundation Trust, York, UK
- 8Milton Keynes University, Hospital NHS Foundation Trust, Milton Keynes, UK
- ↵+Correspondence David Wyllie, Public Health England, Forvie Site, Addenbrookes’ Campus, Robinson Way, Cambridge, CB2 0SR., david.wyllie{at}phe.gov.uk